Latest TPTX reports update at 2022-08-08: 2022-Q22022-Q12021-Q4
Turning Point Therapeutics logo
Turning Point Therapeutics TPTX
$ 75.16 -0.13%

Turning Point Therapeutics Financial Statements 2011-2024 | TPTX

Annual Financial Statements Turning Point Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.32 B 5.29 B 1.46 B - - - - - - - -

Shares

49.3 M 42.2 M 24.1 M - - - - - - - -

Historical Prices

47.7 122 62.3 - - - - - - - -

Net Income

-237 M -157 M -72.1 M -24.8 M -16.6 M - - - - - -

Revenue

30.8 M 25 M - - - - - - - - -

Cost of Revenue

- - - - - - - - - - -

Gross Profit

- 25 - - - - - - - - -

Operating Income

-238 M -162 M -77.7 M -25.6 M -16.7 M - - - - - -

Interest Expense

- - - - - - - - - - -

EBITDA

-237 M -159 M -76.1 M -25.5 M -16.7 M - - - - - -

Operating Expenses

269 M 187 M 77.7 M - - - - - - - -

General and Administrative Expenses

75.8 M 73.4 M 19.8 M 4.58 M 1.49 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Turning Point Therapeutics

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - 49.7 M 49.6 M 49.6 M 49.4 M 49.2 M 48.9 M 46.6 M 42.2 M 38.6 M 35.9 M 35.9 M 32.3 M 24.5 M 3.41 M 3.41 M 3.39 M 3.38 M 3.37 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - -123 M -74.4 M - -66.3 M -56.3 M -35.5 M -47.4 M -17.7 M -31.5 M -60.7 M -21 M -20.5 M -17.1 M -13.5 M -9.02 M -6 M -5.04 M -4.73 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - 119 K 429 K - 460 K 5.16 M 25.2 M - 25 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - -124 M -74.9 M - -66.7 M -56.7 M -36 M -47.9 M -18.5 M -32.7 M -62.6 M -23.1 M -22.1 M -18.5 M -14.1 M -9.48 M -6.13 M -5.17 M -4.86 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - - - - - 1.66 M 1.31 M 518 K - 132 K 135 K 127 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -124 M -74.5 M - -66.4 M -56.4 M -35.8 M -47.9 M -18.3 M -32.5 M -62.4 M -23.1 M -22 M -18.4 M -14 M -9.48 M -6.1 M -5.15 M -4.84 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - 124 M 75.4 M - 67.1 M 61.8 M 61.3 M - 43.5 M 32.7 M 62.6 M - 22.1 M 18.5 M 14.1 M - 6.13 M 5.17 M 4.86 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - 37.7 M 20.3 M - 18.2 M 17.2 M 20 M - 11.3 M 8.58 M 39.9 M - 5.5 M 4.74 M 3.61 M - 1 M 803 K 516 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency